Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


The Right Therapy for Neurological Disorders

From Randomized Trials to Clinical Practice

Editor(s): Beghi E. (Milan) 
Logroscino G. (Bari/Tricase) 

Status: available   
Publication year: 2016
Buy this book
Digital Version: CHF 132.00, EUR 123.00, USD 155.00
Print Version: CHF 132.00, EUR 123.00, USD 155.00
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.
Order this title

You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.

This book belongs to
Frontiers of Neurology and Neuroscience , Vol. 39
Editor(s): Bogousslavsky J. (Montreux) 
X + 168 p., 18 fig., 1 in color, 16 tab., hard cover, 2016
Status: available   
ISSN: 1660-4431
e-ISSN: 1662-2804

Getting neurological patients on the right drug with the right dose at the right time
Most neurological disorders are chronic and aging-related. With the increase of life expectancy their incidence and prevalence will grow in the decades to come, which in turn will increase the load on medical and social systems worldwide. There is thus a desperate need for successful preventive and therapeutic measures based on randomized clinical trials (RTCs) conducted by independent organizations.

This book provides a compendium relating most of the principles of reliable RTCs to specific neurological diseases. Contributed by specialized neurologists, the articles touch on important aspects of RCTs with a clear critical approach, highlighting their limitations as well as giving recommendations for their planning and conducting to address the variable genotypic and phenotypic aspects of neurological conditions. Consideration is also given to combining the clinical impact of the study results with patients’ values and the interests of pharmaceutical companies.

Neurologists involved in clinical trials will certainly benefit from this book, which should become a basic text for all neurological courses dealing with evidence-based neurology.